5 
III. NIH Activities Following Release of the Guidelines 
These include: 
(1) Office of Recombinant DNA Activities 
To facilitate implementation of the Guidelines, the NIH, in June, 
established the Office of Recombinant DNA Activities: to administer and 
coordinate intramural and extramural activities at the NIH; to review the 
institutional biohazards committees and certification statements; and to 
monitor reports and information concerning accidents, containment, and 
safety research innovation. This office is also responsible for establish' 
ing a national registry of recombinant DNA research which will include the 
coding of projects from other agencies. 
(2) Published Proceedings 
In August, the NIH published a volume containing the transcript of 
the February NIH public hearing on the proposed guidelines, as well as 
related correspondence received by the Director, NIH, and the results of 
relevant meetings held prior to the release of the guidelines in June. 
A second volume is planned for publication in late Spring documenting the 
correspondence that the NIH received on the guidelines, the Environmental 
Impact Statement, and the Departmental patent policy. 
[ 830 ] 
